# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-25-000063
Filing Date
2025-11-07
Accepted
2025-11-07 16:04:41
Documents
77
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lgnd-20250930.htm iXBRL | 10-Q | 1603488
2 | EX-19.1 | exhibit191_insidertradingc.htm | EX-19.1 | 105034
3 | EX-31.1 | lgnd_93025exhibit311.htm | EX-31.1 | 15007
4 | EX-31.2 | lgnd_93025exhibit312.htm | EX-31.2 | 15277
5 | EX-32.1 | lgnd_93025exhibit321.htm | EX-32.1 | 11054
11 | LIGAND LOGO | lgnd-20250930_g1.jpg | GRAPHIC | 43732
| Complete submission text file | 0000886163-25-000063.txt |  | 10384771

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lgnd-20250930.xsd | EX-101.SCH | 69743
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lgnd-20250930_cal.xml | EX-101.CAL | 112664
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lgnd-20250930_def.xml | EX-101.DEF | 482705
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lgnd-20250930_lab.xml | EX-101.LAB | 947035
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lgnd-20250930_pre.xml | EX-101.PRE | 675114
80 | EXTRACTED XBRL INSTANCE DOCUMENT | lgnd-20250930_htm.xml | XML | 1434733

Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 251462550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)